Skip to main content
. Author manuscript; available in PMC: 2015 Apr 2.
Published in final edited form as: Leuk Lymphoma. 2014 Apr 22;56(1):65–71. doi: 10.3109/10428194.2014.903589

Figure 3.

Figure 3

Cox proportional hazards model for overall survival adjusted by demographics, year of diagnosis and clinical factors among elderly patients with diffuse large B-cell lymphoma from 2000 to 2006 (n = 8262). Note: all patients were censored at 36 months of follow-up. ACR, anthracycline-containing regimen; R, rituximab.